Press Releases Kamada Ltd.

Equities

KMDA

IL0010941198

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 08:11:19 16/05/2024 BST			5-day change	1st Jan Change
2,056 ^ILa	-0.19%		-1.34%	-7.68%

05-08	Transcript : Kamada Ltd., Q1 2024 Earnings Call, May 08, 2024
05-08	Kamada Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kamada: Q1 Earnings Snapshot	05-08	AQ
Kamada : Financial Highlights for the Three Months Ended March 31, 2024	05-08	PU
Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance	05-08	AQ
Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	05-01	AQ
Kamada: Q4 Earnings Snapshot	03-06	AQ
Kamada : Reports Fiscal Year and Fourth Quarter 2023 Financial Results, CEO letter and presentation	03-06	PU
Kamada : 20F 2023 Annual Report	03-06	PU
Kamada Issues 2024 CEO Letter to Shareholders	03-06	AQ
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability	03-06	AQ
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024	02-28	AQ
Kamada : Results of Annual General Meeting of Shareholders held on December 28, 2023	12-28	PU
Kamada : Other Information - Form 6-K	12-28	PU
PRISM MarketView Biotech Index Top Mover Spotlight: Kamada Ltd.	12-08	AQ
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years	12-06	AQ
KAMADA : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	11-13	PU
Kamada: Q3 Earnings Snapshot	11-13	AQ
Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance	11-13	AQ
Kamada to Announce Third Quarter and First Nine Months Ended September 30, 2023 Financial Results and Host Conference Call on November 13, 2023	11-08	AQ
Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data	16/10/23	AQ
Kamada : Provides Corporate Update on its Israel Operations	10/10/23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kamada Ltd.

Equities

KMDA

IL0010941198

Press Releases

Filters